UNIT 3.docx
UNIT 3.docx
Drug Dissolution
The pharmaceutical phase includes the disintegration of a pill or capsule in the
gastrointestinal tract, the release of the drug contained within, and its dissolution. This is
followed by the pharmacokinetic and pharmacodynamic phases.
The process of solubilisation of drug is drug dissolution.
Drugs are normally taken orally as tablets or capsules. A tablet is usually a compressed
preparation that contains 5–10% of the drug, 80% of fillers, disintegrants, lubricants, glidants,
and binders, and 10% of compounds which ensure easy disintegration, disaggregation, and
dissolution of the tablet in the stomach or the intestine—a process which is defined as the
pharmaceutical phase of drug action.
The drug itself needs to dissolve in aqueous solution at a controlled rate. Such factors as
particle size and crystal form can significantly affect dissolution. Fast dissolution is not
always ideal. For example, slow dissolution rates can prolong the duration of action or avoid
initially high plasma levels.
Acid-Base Properties
Diagram illustrating the key properties that are influenced by the acid/base character of drugs.
Each node highlights an important facet of drug discovery and development.
Acidic and basic characteristics, in combination with whole molecule lipophilicity, affect
drug behaviour in a number of broad areas:
● Molecular interactions with the target macromolecule
● Passage across cells [permeability, absorption and distribution]
● Toxicity [e.g., hERG channel blockade, phospholipidosis]
● Pharmacokinetics [clearance, plasma and tissue binding, metabolism]
● Formulation [dissolution within the GI tract, stability], and
● Environmental impact
Acid-Base Properties
A large number of drugs exhibit typical colloidal behaviour in aqueous solution in that they
accumulate at interfaces, i.e., they are surface active.
Thus, these molecules lower the surface tension of water and form aggregates at sufficiently
high concentrations, resembling micelles that are produced with surfactants.
Typical examples of drugs that produce such surface activity and association are the
antihistamines, e.g., diphenylmethane derivatives (such as diphenhydramine), chlorcyclizine,
chlor-promazine, and tricyclic antidepressants (such as amitriptyline).
Surface active drugs of quite different chemical structure are reported to self-associate and
bind to membranes, causing disruption and solubilization, in a detergent-like manner.
The aggregation of surface-active drugs follows the same principles as classical detergents.
While some drugs display the ability to self-associate forming closed, micelle-like structures,
others aggregate by continuous stacking. When micelles are formed, their aggregation
number usually is small. Drug self-association is also temperature, ionic strength, and pH
dependent.
Bioavailability
Bioavailability refers to how quickly and how much of a particular drug reaches the blood
supply once all the problems associated with absorption, distribution, metabolism, and
excretion have been taken into account. Oral bioavailability (F) is the fraction of the
ingested dose that survives to reach the blood supply.
This is an important property when it comes to designing new drugs and should be
considered alongside the pharmacodynamics of the drug (i.e., how effectively the drug
interacts with its target).
If the log P values are spread over a large range, then the equation will
be parabolic:
When carrying out a Hansch analysis, it is important to choose the substituents carefully to
ensure that the change in biological activity can be attributed to a particular parameter.
Substituting this into the first equation and rearranging leads to the Scatchard equation, where
both [LR] and [L] are measurable:
A Scatchard plot is drawn which compares the ratio [LR]/[L] versus [LR]. This gives a
straight line; the point where it meets the x-axis represents the total number of receptors
available (Rtot) (line A). Th e slope is a measure of the radioligand's affinity for the receptor
and allows Kd to be determined.
A problem related to Michaelis-Menton kinetics is the fact that there may not be sufficient
data points to determine whether the curve of the Michaelis-Menton plot has reached a
maximum value or not. Th is means that values for the maximum rate and KM are likely to be
inaccurate.
More accurate values for these properties can be obtained by plotting the reciprocals of the
rate and the substrate concentration to give a Lineweaver-Burk plot.
The maximum rate can then be obtained from the intersect of the line with the y-axis, while
KM can be obtained from the slope of the line or the intersect with the x-axis.